You may also like...
Posted: August 10, 2017
Shifting borders, crossing boundaries: The case of combined central and peripheral demyelinationMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Small Study Suggests Possible Benefit for Skin Patch to Reduce Immune Activity in Multiple Sclerosis
Posted: January 20, 2014
Small Study Suggests Possible Benefit for Skin Patch to Reduce Immune Activity in Multiple Sclerosis/About-the-Society/News/Small-Study-Suggests-Possible-Benefit-for-Skin-Pat … read morePosted At: National MS Society
Posted: October 26, 2017
Computational simulations suggest multiple sclerosis is a single diseaseNew research supports the idea that multiple sclerosis (MS), which has widely varying symptoms and progression in different patients, is nonetheless a single disease with common...
CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma
Posted: June 28, 2017
CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphomaMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Posted: December 22, 2014
Society Grantees Test Vibrating Insoles for Improving Walking and Balance/About-the-Society/News/Society-Grantees-Test-Vibrating-Insoles-for-Improv … read morePosted At: National MS Society
Join Our Mailing List
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis